Literature DB >> 18991585

Artificial membrane assays to assess permeability.

Bernard Faller1.   

Abstract

This paper reviews the development of artificial membrane assays in the last decade. Reasons why parallel artificial membrane assays (PAMPA) became widely used are discussed and the various PAMPA assays targeting gastro-intestinal absorption, blood brain barrier and skin penetration are presented. Improvements in the assay technology like the introduction of a paracellular component and the critical factors to get quality data are reviewed. The question how does PAMPA compare with Caco-2 monolayer permeability is being addressed. New dimensions in artificial membrane assays like octanol/water logP measurement, influence of excipients on solubility/permeability and binding constants measurements are introduced. Finally, similarity and differences between partition coefficients and permeability values are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991585     DOI: 10.2174/138920008786485227

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  10 in total

1.  A Microfluidic Diffusion Cell for Fast and Easy Percutaneous Absorption Assays.

Authors:  Christophe Provin; Alexandre Nicolas; Sébastien Grégoire; Teruo Fujii
Journal:  Pharm Res       Date:  2015-02-28       Impact factor: 4.200

2.  Direct inhibitors of InhA are active against Mycobacterium tuberculosis.

Authors:  Ujjini H Manjunatha; Srinivasa P S Rao; Ravinder Reddy Kondreddi; Christian G Noble; Luis R Camacho; Bee H Tan; Seow H Ng; Pearly Shuyi Ng; Ng L Ma; Suresh B Lakshminarayana; Maxime Herve; Susan W Barnes; Weixuan Yu; Kelli Kuhen; Francesca Blasco; David Beer; John R Walker; Peter J Tonge; Richard Glynne; Paul W Smith; Thierry T Diagana
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

3.  Discovery and structure-based optimization of adenain inhibitors.

Authors:  Aengus Mac Sweeney; Philipp Grosche; David Ellis; Keith Combrink; Paul Erbel; Nicola Hughes; Finton Sirockin; Samu Melkko; Anna Bernardi; Paul Ramage; Nadine Jarousse; Eva Altmann
Journal:  ACS Med Chem Lett       Date:  2014-06-20       Impact factor: 4.345

4.  Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors.

Authors:  Klemens Hoegenauer; Nicolas Soldermann; Frédéric Stauffer; Pascal Furet; Nadege Graveleau; Alexander B Smith; Christina Hebach; Gregory J Hollingworth; Ian Lewis; Sascha Gutmann; Gabriele Rummel; Mark Knapp; Romain M Wolf; Joachim Blanz; Roland Feifel; Christoph Burkhart; Frédéric Zécri
Journal:  ACS Med Chem Lett       Date:  2016-06-02       Impact factor: 4.345

5.  Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV/AIDS patients in Africa-- implications for herb-drug interactions.

Authors:  Charles Awortwe; Patrick J Bouic; Collen M Masimirembwa; Bernd Rosenkranz
Journal:  Drug Metab Lett       Date:  2014-07

Review 6.  Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

Authors:  A Chen; M L Yarmush; T Maguire
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

7.  Anti-Trypanosomal Proteasome Inhibitors Cure Hemolymphatic and Meningoencephalic Murine Infection Models of African Trypanosomiasis.

Authors:  Srinivasa P S Rao; Suresh B Lakshminarayana; Jan Jiricek; Marcel Kaiser; Ryan Ritchie; Elmarie Myburgh; Frantisek Supek; Tove Tuntland; Advait Nagle; Valentina Molteni; Pascal Mäser; Jeremy C Mottram; Michael P Barrett; Thierry T Diagana
Journal:  Trop Med Infect Dis       Date:  2020-02-17

8.  Real-Time Parallel Artificial Membrane Permeability Assay Based on Supramolecular Fluorescent Artificial Receptors.

Authors:  Suhang He; Anxhela Zhiti; Andrea Barba-Bon; Andreas Hennig; Werner M Nau
Journal:  Front Chem       Date:  2020-11-03       Impact factor: 5.221

9.  Permeation Studies across Symmetric and Asymmetric Membranes in Microdroplet Arrays.

Authors:  Simon Bachler; Marion Ort; Stefanie D Krämer; Petra S Dittrich
Journal:  Anal Chem       Date:  2021-03-15       Impact factor: 6.986

10.  A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.

Authors:  Ujjini H Manjunatha; Sumiti Vinayak; Jennifer A Zambriski; Alexander T Chao; Tracy Sy; Christian G Noble; Ghislain M C Bonamy; Ravinder R Kondreddi; Bin Zou; Peter Gedeck; Carrie F Brooks; Gillian T Herbert; Adam Sateriale; Jayesh Tandel; Susan Noh; Suresh B Lakshminarayana; Siau H Lim; Laura B Goodman; Christophe Bodenreider; Gu Feng; Lijun Zhang; Francesca Blasco; Juergen Wagner; F Joel Leong; Boris Striepen; Thierry T Diagana
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.